FENOPROFEN CALCIUM Drug Patent Profile
✉ Email this page to a colleague
When do Fenoprofen Calcium patents expire, and what generic alternatives are available?
Fenoprofen Calcium is a drug marketed by Am Therap, Halsey, Misemer, Par Pharm, Quantum Pharmics, Rising, Warner Chilcott, Watson Labs, Ani Pharms, Dava Pharms Inc, Ivax Sub Teva Pharms, Pharmaco, Strides Pharma Intl, Sun Pharm Industries, Usl Pharma, and Watson Labs Teva. and is included in thirty-two NDAs.
The generic ingredient in FENOPROFEN CALCIUM is fenoprofen calcium. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the fenoprofen calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fenoprofen Calcium
A generic version of FENOPROFEN CALCIUM was approved as fenoprofen calcium by RISING on July 18th, 2022.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FENOPROFEN CALCIUM?
- What are the global sales for FENOPROFEN CALCIUM?
- What is Average Wholesale Price for FENOPROFEN CALCIUM?
Summary for FENOPROFEN CALCIUM
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 32 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 1 |
| Patent Applications: | 125 |
| What excipients (inactive ingredients) are in FENOPROFEN CALCIUM? | FENOPROFEN CALCIUM excipients list |
| DailyMed Link: | FENOPROFEN CALCIUM at DailyMed |
Recent Clinical Trials for FENOPROFEN CALCIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Pharmacology for FENOPROFEN CALCIUM
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for FENOPROFEN CALCIUM
Anatomical Therapeutic Chemical (ATC) Classes for FENOPROFEN CALCIUM
US Patents and Regulatory Information for FENOPROFEN CALCIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072902-001 | Dec 21, 1990 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmaco | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072267-001 | Aug 17, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Usl Pharma | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072362-001 | Aug 17, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Quantum Pharmics | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072194-001 | Aug 17, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Am Therap | FENOPROFEN CALCIUM | fenoprofen calcium | CAPSULE;ORAL | 072307-001 | Aug 22, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Warner Chilcott | FENOPROFEN CALCIUM | fenoprofen calcium | CAPSULE;ORAL | 072472-001 | Apr 30, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
